AKRO insider trading
CIK 1744659Akero Therapeutics, Inc.: insider trade history from SEC Form 4 filings.
AKRO insider activity at a glance
FilingIQ tracks 760 insider transactions for AKRO in filings since Jun 24, 2019. The most recent transaction is dated Dec 9, 2025. They were reported by 31 insiders.
Across the full history, 24 open-market purchases
and 441 open-market sales
were filed under transaction codes P and S respectively. Compensatory share awards
(code A) and option exercises (code M) are tracked separately and not counted here.
How FilingIQ classifies each line, and the seven facts it shows on every open-market purchase and sale, are documented on the methodology page.
Latest AKRO Form 4 filings
Most recent disclosures. Sign up to filter by transaction code, insider role or dollar value.
Tickers with similar insider activity
Ranked next to AKRO by Form 4 lines in the last 90 days, the number on each card.
Frequently asked
- How many insider trades does FilingIQ track for AKRO?
- FilingIQ tracks 760 Form 4 insider transactions for AKRO (Akero Therapeutics, Inc.), covering filings from Jun 24, 2019 onwards. 0 of those are dated within the last 90 days.
- Are AKRO insiders net buyers or net sellers?
- Across the full Form 4 history for AKRO, 24 transactions (3%) were open-market purchases and 441 (58%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
- Where does AKRO insider data come from?
- Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ links every filing to the insider's SEC CIK, marks plan trades, tax withholding, option exercises, gifts, derivatives and amendments, and shows each open-market purchase and sale with the same fixed facts. It does not rate the stock.
Methodology & sources
Every AKRO insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Institutional holder counts come from the quarter's SEC Form 13F reports. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). How lines are classified and which facts FilingIQ adds is documented on the methodology page; the people behind it are on the team page. Not investment advice; see disclaimer.